Author Details

Новик, А. В

Issue Section Title File
No 8 (2016) Articles COMBINATION OF VEMURAFENIB+KOBIMETINIB FUNDAMENTALLY CHANGES PROGNOSIS FOR METASTATIC MELANOMA
No 17 (2016) Articles ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
No 7 (2018) Articles PRINCIPLES OF MODERN IMMUNOTHERAPY
Vol 26, No 7 (2019) Articles Prognostic markers for testicular germ cell tumors. Research perspectives
Vol 26, No 7 (2019) Articles The role of peripheral blood immunological parameters as predictive markers in cancer patients: the prognostic role of the neutrophil/lymphocyte ratio
Vol 26, No 7 (2019) Articles Modern immunotherapy for kidney cancer
Vol 26, No 7 (2019) Articles PEComas: what are the treatment options? Literature review and personal experience
Vol 27, No 7 (2020) Articles Comparison of systems for evaluating the effectiveness of modern immunotherapy
Vol 27, No 11 (2020) Articles Ten-year experience of pharmacotherapy for soft tissue sarcomas
Vol 27, No 11 (2020) Articles The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
Vol 28, No 7 (2021) Articles Experience of using prolgolimab in real clinical practice
Vol 28, No 7 (2021) Articles Immunological aspects of metronomic chemotherapy regimens
Vol 28, No 7 (2021) Articles Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma
Vol 28, No 11 (2021) Articles Neoadjuvant immunotherapy for non-small cell lung cancer
Vol 29, No 7 (2022) Articles The use of pazopanib in the treatment of disseminated soft tissue sarcoma: personal experience
Vol 29, No 11/12 (2022) Articles Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies